Hyperuricemia in Birds and Dietary Therapy

Jul 8, 2026 | Learning Center

Hyperurlcemia in Birds and Dietaray Therapy

Bianca Murphy, DVM, DABVP (Avian Practice)

Confirm the Diagnosis: Not All Hyperuricemia Is Renal in Origin

Just as elevated BUN and creatinine in dogs and cats must be interpreted in the context of pre-renal, renal, and post-renal causes, uric acid (UA) in birds should be approached with the same diagnostic framework. Hyperuricemia alone is not synonymous with primary renal disease. UA reflects the excretory functional capacity of the renal proximal tubules, and elevations can occur secondary to any condition that reduces tubular secretory function, impairs renal perfusion, or obstructs urine outflow.

Pre-renal causes include severe dehydration, reduced cardiac output, and, critically in older companion birds, atherosclerosis. Renal causes include but are not limited to infectious nephritis, renal injury, hypovitaminosis A, heavy metal toxicosis, and neoplasia. Post-renal causes involve urine outflow obstruction, which is often secondary to cloacal disease. [1]

Atherosclerosis as a Pre-Renal Cause: The Most Commonly Overlooked Etiology in Older Birds

Atherosclerosis is highly prevalent among captive psittacine birds and represents a leading, yet frequently overlooked, pre-renal contributor to hyperuricemia in geriatric patients. Atherosclerotic plaques develop progressively at the intimal layer of major arteries, causing stenosis, abnormal vascular flow, and loss of endothelial integrity—magnitudes that can reduce renal perfusion and consequently impair uric acid clearance. [2]

Clinically, cardiovascular disease secondary to atherosclerosis may present with subtle or nonspecific signs, including exercise intolerance, dyspnea, neurologic changes, or even sudden death. [3] If atherosclerosis is the primary driver of reduced renal perfusion, then dietary protein restriction will not address the underlying etiology and may in fact be counterproductive, as discussed below.

Avian Renal Anatomy and Physiology: A Critical Distinction

Birds possess fundamental anatomic and physiologic differences from mammals that profoundly affect how we interpret renal biomarkers and how we think about dietary intervention. In contrast to the mammalian kidney, avian kidneys contain two types of nephrons:

  • Cortical (reptilian-type) nephrons: Comprise up to 90% of all nephrons and notably lack the loop of Henle.
  • Medullary (mammalian-type) nephrons: Possess long loops of Henle extending into the medulla. [4]

The critical functional consequence of this dual-nephron architecture is that uric acid is excreted almost entirely via active tubular secretion in the proximal tubules, a mechanism that is independent of glomerular filtration rate (GFR) and tubular urine flow. [4,5] Approximately 90% of uric acid excretion occurs this way. [6] This is fundamentally different from the urea-based waste excretion pathway in dogs and cats, where GFR is the primary driver of nitrogen clearance.

Additionally, birds have no urinary bladder. Water conservation occurs via reabsorption in the coprodeum and rectum rather than through urinary concentration, a process that is limited in birds due to the absence of the loop of Henle in the majority of avian nephrons. [4] Because of these differences, an estimated 70% of renal function must be lost before plasma uric acid becomes elevated, meaning hyperuricemia, when truly renal in origin, indicates significant and advanced tubular disease. [4]

“Birds possess fundamental anatomic and physiologic differences from mammals that profoundly affect how we interpret renal biomarkers and how we think about dietary intervention.”

Why Protein Restriction Works in Dogs and Cats, and Why It Does Not Translate Directly to Birds

The Mammalian Rationale for Protein Restriction

In dogs and cats with chronic kidney disease (CKD), dietary protein restriction is a well-established component of management. Its benefits are mechanistic: reduced protein intake lowers the production of uremic toxins, including BUN and protein-derived microbial metabolites such as indoxyl sulfate and p-cresol sulfate, which accumulate as GFR declines and have systemic toxic effects. [7] These toxins are associated with accelerated renal disease progression, cardiovascular complications, and neurological changes. [7]

Protein restriction also reduces proteinuria, decreases renal oxidative stress, and, in conjunction with phosphorus restriction, slows the progression of CKD. [8] Clinical trials in both cats and dogs have demonstrated that therapeutic renal diets can reduce uremic crises and double survival time compared to maintenance diets. [8,9]

Why This Rationale Does Not Apply to Birds

The mammalian model of protein restriction for CKD is predicated on reducing urea and uremic toxin accumulation that results from impaired glomerular filtration. In birds, this framework does not apply for several reasons:

  1. Uricotelic Metabolism: Birds excrete nitrogen as uric acid rather than urea. Uric acid excretion is driven by proximal tubular secretion, not by GFR. Therefore, dietary protein load does not translate to uremic toxin accumulation in the way it does in dogs and cats.
  2. Granivorous Dietary Studies: Research in granivorous birds has directly tested the dietary protein-hyperuricemia hypothesis and found it does not hold. Cockatiels (Nymphicus hollandicus) fed extremely high-protein diets (up to 70% dietary protein) for 11 months did not develop renal lesions. These birds were able to upregulate enzymes associated with amino acid catabolism and uric acid synthesis, and while plasma uric acid rose linearly with protein intake, it remained within normal limits throughout, confirming that hyperuricemia in granivorous birds is specific to renal disease or severe dehydration, not dietary protein excess. [1]

Importantly, the concern for protein-induced nephrotoxicity in birds has largely emerged from poultry production literature, where diets exceeding 42% crude protein fed to very young broiler chicks or diets high in urea were associated with renal changes under specific experimental conditions. [1] These findings do not translate to adult companion psittacines consuming nutritionally balanced formulated diets. Protein restriction in a bird with confirmed renal disease may therefore not reduce uric acid levels, and unnecessary restriction risks lean body mass loss, which is particularly problematic in birds with concurrent cachexia-inducing conditions such as cardiovascular disease.

Dietary Recommendations: Caloric Needs Should Drive Diet Selection

In light of the above, dietary management in the avian patient with suspected or confirmed renal disease should be guided primarily by the bird’s caloric requirements, body condition, and concurrent disease burden, not by protein restriction for its own sake.

Obese Patients

For overweight birds, transitioning from Harrison’s High Potency to Harrison’s Adult Lifetime formula is a reasonable dietary adjustment to reduce caloric density. This transition should be accompanied by daily measured food volumes to ensure appropriate caloric intake without excess. Obesity is itself a risk factor for cardiovascular disease and metabolic disorders in psittacines, so weight management has independent merit. [3]

Patients with Reduced Appetite or Cachexia-Prone Disease

Birds presenting with poor appetite or those diagnosed with conditions known to cause progressive lean body mass loss, most notably cardiovascular disease secondary to atherosclerosis, may benefit from remaining on or continuing Harrison’s High Potency formula rather than transitioning to Lifetime. Ensuring adequate caloric and protein intake is essential for these patients to prevent further muscle wasting and support immune and organ function. Cachexia in avian patients with cardiac disease is a recognized sequela, [3] and nutritional support should be calibrated to meet, not restrict, their needs.

A Note on Harrison’s HOPP Formula

Harrison’s HOPP (High Potency Organic Premium Pellets) is a maintenance diet formulated specifically for small to medium-sized birds. It has only been evaluated in birds within this size range and is not currently intended for use as a therapeutic diet in patients with active disease. It should not be substituted for High Potency or Lifetime in clinical management scenarios until further validation data are available for avian patients across different health states.

“Avoid routine protein restriction in birds; avian uric acid excretion is tubular secretion-driven and largely independent of dietary protein load in healthy granivorous species.”

Summary of Recommendations

Before initiating any dietary change in a bird with suspected renal disease:

  1. Characterize the cause of hyperuricemia as pre-renal (including atherosclerosis and dehydration), primary renal, or post-renal.
  2. Investigate for cardiovascular disease in older birds, particularly African grey parrots, Amazons, and cockatiels, before attributing elevated uric acid to intrinsic renal pathology.
  3. Avoid routine protein restriction in birds; avian uric acid excretion is tubular secretion-driven and largely independent of dietary protein load in healthy granivorous species.
  4. Tailor diet selection to body condition and disease status: High Potency vs. Lifetime based on caloric needs, with daily measured portions.
  5. Reserve HOPP as a maintenance-only diet for small to medium-sized birds in good health; it is not validated as a therapeutic option at this time.

References

  1. Cojean O, Larrat S, Vergneau-Grosset C. Clinical Management of Avian Renal Disease. Vet Clin North Am Exot Anim Pract. 2020;23(2):333-350. https://doi.org/10.1016/j.cvex.2020.01.002
  2. Beaufrère H. Avian Atherosclerosis: Parrots and Beyond. J Exot Pet Med. 2013;22(4):336-347. https://doi.org/10.1053/j.jepm.2013.07.003
  3. Pees M, et al. Heart Disease in Pet Birds – Diagnostic Options. Vet Clin North Am Exot Anim Pract. 2022;25(2). https://doi.org/10.1016/j.cvex.2022.01.004
  4. Lierz M. Avian Renal Disease: Pathogenesis, Diagnosis, and Therapy. Vet Clin North Am Exot Anim Pract. 2003;6(1):29-55. https://doi.org/10.1016/S1094-9194(02)00029-4
  5. Renfro JL, Balment RJ. Avian Renal Proximal Tubule Epithelium Urate Secretion is Mediated by Mrp4. Am J Physiol Regul Integr Comp Physiol. 2009;296(3):R532-R540. https://doi.org/10.1152/ajpregu.90471.2008
  6. Schmidt RE, Reavill DR. Confirming a Diagnosis of Renal Disease in the Avian Patient. Proc Annu Conf Assoc Avian Vet. Harrison’s Bird Foods Reference Archive. 2024.
  7. Ephraim E, Jewell DE. High Protein Consumption with Controlled Phosphorus Level Increases Plasma Concentrations of Uremic Toxins in Cats with Early Chronic Kidney Disease. Herald Open Access. 2021.
  8. Parker VJ. Nutritional Management for Dogs and Cats with Chronic Kidney Disease. Vet Clin North Am Small Anim Pract. 2021;51(5):1-15. https://doi.org/10.1016/j.cvsm.2021.04.009
  9. Ward E, Lund EM. Nutritional Management of Chronic Kidney Disease in Cats & Dogs. Today’s Vet Practice. 2022. https://todaysveterinarypractice.com/nutrition/acvn-nutrition-notes

This document reflects Harrison’s Bird Foods’ current understanding of avian renal disease management as of March 2026. This content is not intended to constitute veterinary medical advice. Any bird with known or suspected medical concerns should be evaluated by a qualified avian veterinarian.

 

Download PDF